Prevalence and genotyping of hepatitis B virus: a cross-sectional study conducted with female sex workers in the Marajo Archipelago, Brazil
Nenhuma Miniatura disponível
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
FRADE, Paula C. R.
RAIOL, Nairis C.
COSTA, Luana M. da
PINHEIRO, Luiz M. L.
SILVA-OLIVEIRA, Glaucia C.
LEMOS, Jose A. R.
MARTINS, Luisa C.
OLIVEIRA-FILHO, Aldemir B.
Citação
INTERNATIONAL JOURNAL OF STD & AIDS, v.30, n.9, p.902-910, 2019
Resumo
In South America, the Amazon basin is considered an endemic area of hepatitis B virus (HBV) infection. However, epidemiological studies with vulnerable groups are scarce. Female sex workers (FSWs) are highly vulnerable to sexually transmitted infections due to a combination of their sexual behavior and socio-economic conditions. Thus, this study investigated the prevalence of HBV infections and HBV-hepatitis C virus, HBV-hepatitis D virus, HBV-HIV, and HBV-human T-lymphotropic virus co-infections among FSWs in the Marajo Archipelago, northern Brazil, as well as identifying the HBV genotypes circulating in this population. A total of 153 FSWs in 5 towns and 18 riverside communities were included in the study. The HBV infection and co-infections were diagnosed by enzyme-linked immunosorbent assay and real-time polymerase chain reaction. The HBV genotypes were detected by sequencing and were then analyzed phylogenetically. Most of the FSWs surveyed were single, young, heterosexual, and born locally, with low levels of education. Overall, 21 (13.7%) had been exposed to HBV, and HBV-DNA was detected in 13 (8.5%). Genotypes A (69.2%), D (23.1%), and F (7.7%) were detected. Seven cases of co-infections with other viruses were detected. These findings indicate a clear need for urgent measures to control the spread of HBV and other pathogens, and to promote the health of the local FSWs.
Palavras-chave
Female sex workers, hepatitis B virus, co-infections, epidemiology, Brazil
Referências
- Caetano KAA, 2013, AIDS PATIENT CARE ST, V27, P1, DOI 10.1089/apc.2012.0268
- Andrade AP, 2017, ARCH VIROL, V162, P227, DOI 10.1007/s00705-016-3060-z
- Aquino Priscila de Souza, 2008, Texto contexto - enferm., V17, P427, DOI 10.1590/S0104-07072008000300003
- Botelho-Souza LF, 2014, J VIROL METHODS, V197, P19, DOI 10.1016/j.jviromet.2013.11.016
- Caterino-De-Araujo A, 2018, MEM I OSWALDO CRUZ, V113, P130, DOI 10.1590/0074-02760170307
- Damacena GN, 2011, J ACQUIR IMMUNE D S3, V57, P144
- de Aguiar SA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2859-x
- de Figueiredo NC, 2008, REV SOC BRAS MED TRO, V41, P590, DOI 10.1590/S0037-86822008000600009
- Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171
- Souto FJD, 2016, REV SOC BRAS MED TRO, V49, P11, DOI 10.1590/0037-8682-0176-2015
- Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94
- Ferreira OD, 2018, MEDICINE, V97, pS3, DOI 10.1097/MD.0000000000009218
- de Oliveira CSF, 2011, REV SOC BRAS MED TRO, V44, P546, DOI 10.1590/S0037-86822011000500003
- Francisco Priscila Maria Stolses Bergamo, 2015, Rev. bras. epidemiol., V18, P552, DOI 10.1590/1980-5497201500030003
- Lampe E, 2017, J GEN VIROL, V98, P1389, DOI 10.1099/jgv.0.000789
- Ministerio da Saude Brasil, 2003, PROGR NAC IM 30 AN C
- Ministerio da Saude Brasil, 2016, HEP VIR CAS CONF NOT
- Braga WSM, 2012, REV SOC BRAS MED TRO, V45, P13, DOI 10.1590/S0037-86822012000100004
- Puga MAM, 2018, REV SOC BRAS MED TRO, V51, P198, DOI 10.1590/0037-8682-0231-2017
- Nigam P K, 2005, Indian J Dermatol Venereol Leprol, V71, P52
- Oliveira EH, 2014, ARCH VIROL, V159, P1193, DOI 10.1007/s00705-013-1921-2
- Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
- Passos Afonso Dinis Costa, 2007, Rev. bras. epidemiol., V10, P517, DOI 10.1590/S1415-790X2007000400010
- Penha Jardeliny Corrêa da, 2015, Rev. Gaúcha Enferm., V36, P63, DOI 10.1590/1983-1447.2015.02.52089
- Pinheiro L. M., 2013, J ANTIVIR ANTIRETROV, V5, P108
- Sant' Anna CD, 2018, J MED VIROL, V90, P1063, DOI 10.1002/jmv.25051
- Schuelter-Trevisol F, 2013, REV SOC BRAS MED TRO, V46, P493, DOI 10.1590/0037-8682-1364-2013
- Silitonga N, 2011, SEX HEALTH, V8, P61, DOI 10.1071/SH10038
- Silva FQ, 2018, ARCH VIROL, V163, P617, DOI 10.1007/s00705-017-3656-y
- Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427
- Tamegao-Lopes BP, 2006, REV SOC BRAS MED TRO, V39, P548, DOI 10.1590/S0037-86822006000600007
- Vallinoto ACR, 2016, ANN HUM BIOL, V43, P397, DOI 10.1080/03014460.2016.1196244